|
BMKK to Break from Long-Listed Drugs: Mr Wright
|
p 1 |
|
Takeda to Shore Up Lifestyle Diseases Area in Japan with New Products
|
p 2 |
|
Astellas Begins Tender Offer to Acquire OSI Pharmaceuticals |
p 4 |
|
Shionogi Licenses Ospemifene from QuatRx |
p 5 |
|
9 Products, Including Pfizer's Lyrica, Recommended for Approval | p 10 |
|
Korosho to Call on Public Hospitals for Earlier Price Settlement |
p 13 |
|
Daiichi Sankyo to Embark on Generics Business in Japan |
p 17 |
|
Astellas Licenses Isavuconazole from Basilea |
p 18 |
|
Legislation of "Specific Nurses" Proposed by Korosho |
p 21 |